HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Figures Only Full Text (PDF) All Versions of this Article: 2253011490v1 225/3/639    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hansell, D. M. Search for Related Content PubMed PubMed Citation Articles by Hansell, D. M.

Small-Vessel Diseases of the Lung: CT-Pathologic Correlates¹

¹ From the Department of Radiology, Royal Brompton Hospital, Sydney St, London SW3 6NP, England. Received September 6, 2001; revision requested November 8; revision received January 4, 2002; accepted January 22. Address correspondence to the author (e-mail: d.hansell@rbh.nthames.nhs.uk).

	ABSTRACT

TOP ABSTRACT INTRODUCTION ANATOMIC AND HISTOLOGIC ASPECTS... CLASSIFICATION OF SMALL-VESSEL... IMAGING TECHNIQUES OCCLUSIVE SMALL-VESSEL DISEASES INFLAMMATORY SMALL-VESSEL... CONCLUSION REFERENCES

 
Diseases that primarily affect the small vessels of the lung are difficult to diagnose. Many conditions are characterized by involvement of small pulmonary vessels, and pathologically they can be conveniently divided into occluding and inflammatory types. The former, typified by chronic pulmonary thromboembolism and primary pulmonary hypertension, are relatively cryptic in terms of imaging. In contrast, inflammatory vasculitides, which often cause pulmonary hemorrhage and infarction, result in florid but nonspecific radiographic abnormalities. The spectrum of thin-section computed tomographic abnormalities encountered in the inflammatory vasculitides is wide: For example, in Wegener granulomatosis the pattern ranges from cavitating nodules to lobar consolidation to ground-glass opacity. This review highlights some of the less obvious imaging manifestations of occlusive and inflammatory diseases of the small pulmonary vessels.

© RSNA, 2002

Index terms: Hypertension, pulmonary, 944.723 • Lung, CT, 60.12111, 60.12112, 60.12118 • Lung, hemorrhage, 60.4123 • Lung, vascular disease, 50.781, 50.783, 50.788, 60.622, 60.623, 60.691, 60.692, 60.71 • State of the Art

	INTRODUCTION

TOP ABSTRACT INTRODUCTION ANATOMIC AND HISTOLOGIC ASPECTS... CLASSIFICATION OF SMALL-VESSEL... IMAGING TECHNIQUES OCCLUSIVE SMALL-VESSEL DISEASES INFLAMMATORY SMALL-VESSEL... CONCLUSION REFERENCES

 
The imaging, and understanding, of conditions that affect the small vessels of the lung is a challenge. Many of the difficulties encountered in considering diseases of the small vessels are mirrored in small-airways diseases: Problems include the definition of anatomic criteria for what constitutes a "small vessel," the utility of clinical versus pathologic classification, the nonspecific and often late clinical manifestation of such diseases, the continuum between small- and large-vessel involvement, and, finally, the lack of specific radiographic findings in most of these diseases.

Although some diseases affecting the small vessels elude a precise clinical or histologic diagnosis, for reasons explored later, an increasing array of thin-section computed tomographic (CT) features can be used to corroborate small-vessel disease as the dominant pathologic process. While acknowledging the less-than-definitive diagnostic role of CT in diseases of the small vessels of the lung, this review will include discussion of those conditions in which an understanding of the pathology can be usefully brought to bear on the interpretation of thin-section CT findings in this difficult group of disorders.

	ANATOMIC AND HISTOLOGIC ASPECTS OF SMALL-VESSEL DISEASES

TOP ABSTRACT INTRODUCTION ANATOMIC AND HISTOLOGIC ASPECTS... CLASSIFICATION OF SMALL-VESSEL... IMAGING TECHNIQUES OCCLUSIVE SMALL-VESSEL DISEASES INFLAMMATORY SMALL-VESSEL... CONCLUSION REFERENCES

 
The point at which pulmonary vessels, in particular pulmonary arteries, can be considered "small" is arguable but has a bearing on whether such vessels are within or below the spatial-resolution capability of thin-section CT. In addition to the size of pulmonary arteries, an important distinction can be made between elastic (larger arteries) versus muscular (smaller arteries) vessels. The larger pulmonary arteries and their intrapulmonary branches with an external diameter of 1 mm or larger have walls constructed of numerous parallel elastic laminae and are therefore termed elastic arteries. For both anatomic and pathologic classification, elastic tissue stains (eg, Verhoeff–van Gieson stain) are invaluable for enabling identification of arterial wall disruption in the inflammatory vasculitides. Pulmonary arteries smaller than 1 mm but larger than 100 µm are characterized by a thin smooth-muscle medial layer (providing less than 7% of the external diameter) bounded by internal and external elastic membranes. Vessels smaller than 100 µm in diameter are termed pulmonary arterioles and are composed of a single layer of endothelial cells on an elastic lamina. The morphologic diminution culminates in the pulmonary capillaries within the alveolar walls: These are smaller than 10 µm in diameter and consist simply of a layer of endothelial cells and basement membrane.

It should be appreciated that this simplified morphologic scheme (1) understates the gradual transition from elastic arteries to muscular arteries to arterioles. For example, because of the spiral configuration of muscular media, there will be some apparently "intermediate" arteries that in perpendicular section will have a muscular media in only part of the wall circumference. It is, therefore, probably inadvisable to categorize pulmonary arteries simply according to diameter, and one proposal has been to classify all precapillary pulmonary arteries as either muscular or nonmuscular (2), although the reality of "transitional" arteries remains. There are no morphologic characteristics on thin-section CT images, apart from size, that allow the distinction between these two fundamental types of pulmonary arteries. If the largely arbitrary definition of pulmonary arterioles as those vessels with a diameter of less than 100 µm is accepted and given the limits of spatial resolution of thin-section CT, which in the most optimal circumstances is approximately 200 µm (3), normal pulmonary arterioles are not directly visualized on standard thin-section CT images. Centrilobular pulmonary arteries, approximately 1 mm in diameter, can be readily recognized on thin-section CT images, particularly in the lung periphery (4).

The pulmonary arteries are accompanied by a similar-sized bronchus throughout their course, at least down to the size that these arteries are visible on thin-section CT images. Below this size, supernumerary arteries branch at right angles and penetrate the more peripheral lung parenchyma within an acinus; thus, there is a complex system of perfusion of the acinus, which receives arterial blood from the axial (central) and several supernumerary (peripheral) arteries (5). The postcapillary vessels converge to form the pulmonary veins, which are located within the interlobular septa; the small pulmonary venules are morphologically identical to arterioles and may only be identified confidently by demonstrating their continuity with a pulmonary vein (1).

Structural similarities between arterioles and venules are relevant to the difficulties that arise in distinguishing between precapillary and postcapillary vascular diseases. The walls of macroscopic pulmonary veins are much thinner than those of similar-sized pulmonary arteries and are composed of an inner elastic lamina and a less well organized peripheral layer of elastic fibers. The bronchial arteries are of systemic origin, and their smaller branches lie within bronchial walls; although there may be anastomotic links with the pulmonary circulation, there are no conditions that exclusively affect the small branches of the bronchial arteries, and the bronchial arterial circulation will not be considered further.

	CLASSIFICATION OF SMALL-VESSEL DISEASES

TOP ABSTRACT INTRODUCTION ANATOMIC AND HISTOLOGIC ASPECTS... CLASSIFICATION OF SMALL-VESSEL... IMAGING TECHNIQUES OCCLUSIVE SMALL-VESSEL DISEASES INFLAMMATORY SMALL-VESSEL... CONCLUSION REFERENCES

 
The lack of a distinctive transitional zone between small and large pulmonary vessels means that any attempt to define "small-vessel disease" precisely is unrealistic; nevertheless, there are enough conditions that are predominantly confined to the smaller branches of the pulmonary vasculature to make this somewhat arbitrary categorization worthwhile. There are many classifications of diseases of the pulmonary vasculature, each with its own idiosyncrasies and problems. Most schemes are defined in terms of one of the following nosologies: (a) size of vessel predominantly involved (6) (eg, medium-sized vasculitis), (b) the predominant pathologic process (eg, granulomatous vasculitis), (c) cause or association (eg, toxic oil syndrome or systemic sclerosis–associated vasculopathy), (d) eponym (eg, Goodpasture syndrome), (e) mechanism (eg, embolic), and (f) constellation of clinical features (eg, antineutrophil cytoplasmic antibody [ANCA] vs non-ANCA). Some classifications of the pulmonary vasculitides can be regarded as a more or less complete list of pathologic conditions affecting the pulmonary vasculature (7) (Fig 1).

View larger version (43K): [in this window] [in a new window] [Download PPT slide]   Figure 1. Example of classification of pulmonary vascular disease. This list is a modification of that by Anderson (7).

The range of imaging abnormalities encountered in the inflammatory vasculitides is wide but in many ways predictable: Inflammatory involvement resulting in hemorrhagic leak and/or infarction results in florid radiographic changes. In contrast, the occlusive vasculitides, typified by chronic pulmonary thromboembolism and primary pulmonary hypertension, are characterized by relatively cryptic and usually indirect imaging signs. The conditions included under these two broad headings and discussed in this review are shown in Table 1.

	IMAGING TECHNIQUES

TOP ABSTRACT INTRODUCTION ANATOMIC AND HISTOLOGIC ASPECTS... CLASSIFICATION OF SMALL-VESSEL... IMAGING TECHNIQUES OCCLUSIVE SMALL-VESSEL DISEASES INFLAMMATORY SMALL-VESSEL... CONCLUSION REFERENCES

Alteration of window settings has a marked effect on the apparent size of structures (11), and, with specific reference to the pulmonary vasculature, smaller vessels are disproportionately and more adversely affected by inappropriate window settings than are larger vessels. Nonstandard window settings may either deemphasize the small vessels or, conversely, produce a nodular appearance in the lungs. Furthermore, subtle regional inhomogeneity in the attenuation of lung parenchyma may become invisible or inconspicuous if a wider than usual window setting is used; in general, a window level of -500 to -800 HU and a width of 900 to 1,500 HU is satisfactory, but a narrow window width of approximately 600 HU may be used to emphasize a subtle mosaic attenuation pattern. Although such latitude in the choice of window settings may be desirable, there is probably no substantial diagnostic gain in using freely adjustable window settings, provided the starting points are conventional width and level settings (12). Allowing for the few parameters that can be altered when performing a standard thin-section CT examination, the final appearance of the lungs obtained with different CT scanners, even when identical window settings are used, can be remarkably different; these differences may be particularly problematic in the context of identifying a mosaic attenuation pattern or assessing the abnormal paucity of small vessels.

The mosaic attenuation pattern on thin-section CT images is a nonspecific sign indicating patchy infiltrative, small-airways, or occlusive vascular disease (13–17). Enhancement of this regional inhomogeneity in the attenuation of the lung parenchyma on sections obtained at end expiration has led to the recommendation that expiratory sections be routinely obtained, irrespective of the findings on standard inspiratory thin-section CT images (18,19). In most cases, expiratory CT images will aid the identification of individuals with small-airways disease as the cause of a mosaic attenuation pattern (20); however, it is possible that the use of expiratory CT images to make the distinction between small-airways and small-vessel disease is not always reliable, particularly in the complex pathophysiologic situations in which airways and vessels are both abnormal (21).

The attenuation differences that characterize a mosaic attenuation pattern, when caused by occlusion of medium- and small-sized pulmonary arteries, may be subtle and close to the limit of visual detection. While optimization (narrowing) of window settings may increase the conspicuity of regional attenuation differences, it will also spuriously affect the apparent extent of abnormal versus normal lung. However, there are simple image-processing techniques that can be used to improve the detection of small attenuation differences within the lung parenchyma. The most widely used and simplest technique is the so-called minimum intensity projection technique, which has been shown to result in improved detection of subtle areas of low attenuation in the context of small-airways disease in emphysema (22,23). Conversely, maximum intensity projection images improve the delineation of medium and small vessels and may emphasize regional differences in their size (24) (Fig 2).

View larger version (160K): [in this window] [in a new window] [Download PPT slide]   Figure 2. Maximum intensity projection image comprising a slab of seven contiguous transverse 1.5-mm-thick CT sections shows to advantage the branching morphology of vessels in the upper lobes.

Parenchymal attenuation disturbances.—Patchy inhomogeneity in the attenuation of lung parenchyma (mosaic attenuation pattern) is a recognized sign of pulmonary vascular disease (13,14,25,26). In the specific context of a vascular cause for this nonspecific pattern, the original term mosaic oligemia (15) is semantically and mechanistically correct (Fig 3). However, the fact that three basic and fundamentally different types of disease (diffuse infiltrative, small-airways, and occlusive vascular diseases) can all cause a mosaic attenuation pattern may, on occasion, cause diagnostic difficulties (16,17).

View larger version (119K): [in this window] [in a new window] [Download PPT slide]   Figure 3. Transverse thin-section CT image through the upper lobes in a 64-year-old woman with chronic thromboembolic disease shows typical mosaic oligemia (mosaic attenuation pattern). Note the smaller caliber of vessels in the low-attenuating portion of (underperfused) lung, as compared with those in areas of increased attenuation (relatively overperfused lung). The proximal subsegmental and segmental pulmonary arteries are abnormally dilated.

View larger version (105K): [in this window] [in a new window] [Download PPT slide]   Figure 4. Transverse thin-section CT image through the mid-lung zones in a 44-year-old woman with mixed small-airways and small-vessel disease. The patient had constrictive obliterative bronchiolitis secondary to a severe viral lower respiratory tract infection; she subsequently developed chronic thromboembolic disease. In this case, it is impossible to be certain what proportion of the mosaic attenuation pattern is ascribable to small-airways, as opposed to small-vessels, disease.

View larger version (106K): [in this window] [in a new window] [Download PPT slide]   Figure 5. Transverse thin-section CT image through the lower lobes in a patient with severe chronic thromboembolic disease and presumed hypoxic bronchodilatation. There are extensive areas of relatively underperfused lung. Peripheral subpleural opacification in the right lower lobe likely reflects previous pulmonary infarction (arrowheads). Note the mildly dilated segmental and subsegmental bronchi (arrow) in the lower lobes, which were also present on adjacent sections (not shown).

Ground-glass opacity and consolidation.—In the context of small-vessel diseases, ground-glass opacity is most frequently seen as the increased-attenuation component (reflecting relative overperfusion) of the mosaic attenuation pattern and is encountered in chronic occlusive vascular disease. Nevertheless, other conditions affecting the small vessels may result in ground-glass opacity by other mechanisms: The commonest is diffuse pulmonary hemorrhage in which there is thickening of the interstitium and partial filling of the airspaces with blood (29). Other conditions affecting the small pulmonary vessels, characterized by ground-glass opacity, include pulmonary veno-occlusive disease (30), acute sickle cell disease (31), Churg-Strauss syndrome (32), and Wegener granulomatosis (33). The pathogenesis of ground-glass opacity will be considered in more detail for each specific disease.

Frank pulmonary consolidation is most often encountered in conditions in which there is pulmonary infarction with or without hemorrhage into the airspaces. The disposition of the consolidation (eg, focal wedge-shaped area in the periphery of the lower lobe) may be suggestive of an area of pulmonary infarction (Fig 6). It is not clear whether consolidation caused by an inflammatory granulomatous or neutrophilic vasculitis eventually results in a visible mosaic attenuation pattern in addition to residual scarring that may be ascribable to inflammatory pulmonary consolidation (34).

View larger version (111K): [in this window] [in a new window] [Download PPT slide]   Figure 6. Standard transverse CT section obtained after intravenous administration of contrast material in a 56-year-old woman with Wegener granulomatosis shows an area of consolidation in the medial segment of the right middle lobe (arrowheads), thought to be an area of organizing pneumonia. Histologic examination of a lung biopsy specimen revealed Wegener granulomatosis.

On occasion, it may be difficult to discriminate between the numerous small but normal pulmonary vessels in dependent lung and an abnormal nodular pattern. However, this distinction can be made more easily with increased data sampling and viewing of the resultant thin sections in cine mode (36). Nevertheless, in specific circumstances, an apparent nodular pattern may indeed reflect an abnormal profusion of vessels, the most obvious example being the hepatopulmonary syndrome associated with liver cirrhosis, in which numerous peripheral minute arteriovenous malformations are seen as a nodular pattern (37). The micronodules associated with various occlusive vasculopathies are poorly defined and of relatively low attenuation (Fig 7) and may be encountered in primary pulmonary arterial hypertension (38), various forms of diffuse pulmonary hemorrhage (29,39), and pulmonary capillary hemangiomatosis (9,40).

View larger version (129K): [in this window] [in a new window] [Download PPT slide]   Figure 7. Transverse thin-section CT image through the upper lobes in a 39-year-old woman with severe primary pulmonary hypertension shows widespread subtle small nodules of relatively low attenuation throughout the lungs; these nodules correspond to focal extravasation of blood and/or cholesterol granuloma formation.

View larger version (123K): [in this window] [in a new window] [Download PPT slide]   Figure 8. Transverse thin-section CT image through the upper lobes in a patient with veno-occlusive disease. Thickening of the interlobular septa is the most prominent feature, and there are some poorly defined centrilobular nodules. Bilateral dependent pleural effusions (arrows) are visible.

View larger version (197K): [in this window] [in a new window] [Download PPT slide]   Figure 9a. Pulmonary tumor thrombotic microangiopathy. (a) Transverse thin-section CT image through the right lower lobe shows small branching opacities (arrows) representing enlarged peripheral arteries. (b) Cut surface of autopsy lung specimen shows pale nodules, which correspond to the pulmonary arteries thickened by the fibrotic reaction to tumor. (c) Photomicrograph demonstrates dense fibrocellular proliferation within an arteriolar lumen. The tumor emboli (arrows) are relatively small. (Image courtesy of Dr T. Franquet, Hospital Sant Pau, Barcelona, Spain.)

View larger version (148K): [in this window] [in a new window] [Download PPT slide]   Figure 9b. Pulmonary tumor thrombotic microangiopathy. (a) Transverse thin-section CT image through the right lower lobe shows small branching opacities (arrows) representing enlarged peripheral arteries. (b) Cut surface of autopsy lung specimen shows pale nodules, which correspond to the pulmonary arteries thickened by the fibrotic reaction to tumor. (c) Photomicrograph demonstrates dense fibrocellular proliferation within an arteriolar lumen. The tumor emboli (arrows) are relatively small. (Image courtesy of Dr T. Franquet, Hospital Sant Pau, Barcelona, Spain.)

View larger version (155K): [in this window] [in a new window] [Download PPT slide]   Figure 9c. Pulmonary tumor thrombotic microangiopathy. (a) Transverse thin-section CT image through the right lower lobe shows small branching opacities (arrows) representing enlarged peripheral arteries. (b) Cut surface of autopsy lung specimen shows pale nodules, which correspond to the pulmonary arteries thickened by the fibrotic reaction to tumor. (c) Photomicrograph demonstrates dense fibrocellular proliferation within an arteriolar lumen. The tumor emboli (arrows) are relatively small. (Image courtesy of Dr T. Franquet, Hospital Sant Pau, Barcelona, Spain.)

	OCCLUSIVE SMALL-VESSEL DISEASES

TOP ABSTRACT INTRODUCTION ANATOMIC AND HISTOLOGIC ASPECTS... CLASSIFICATION OF SMALL-VESSEL... IMAGING TECHNIQUES OCCLUSIVE SMALL-VESSEL DISEASES INFLAMMATORY SMALL-VESSEL... CONCLUSION REFERENCES

 
Primary Pulmonary Hypertension
Primary pulmonary hypertension is the occlusive small-vessel disease par excellence. The pathologic changes are largely confined to the muscular pulmonary arteries (those less than 1 mm in diameter that contain a medial layer of muscle). Changes seen in the macroscopic and large pulmonary arteries (eg, dilatation of the main pulmonary arteries seen on a chest radiograph) are a response to the pulmonary hypertension, rather than muscle hypertrophy per se, which characterizes primary pulmonary hypertension (45). Primary (idiopathic) pulmonary hypertension is a rare and often overlooked diagnosis, and, given the numerous conditions that can cause pulmonary hypertension (at least 30 causes in the World Health Organization classification of pulmonary hypertension [46,47]), the diagnosis is usually one of exhaustive exclusion.

The histologic grading of pulmonary hypertension (1) ranges from minor changes of hypertrophy of the muscular media of the small pulmonary arteries, to subendothelial fibrous proliferation, to the development of "plexiform lesions" (nothing more than aneurysmal expansion of a sclerotic damaged vessel with associated minute abnormal vascular channels in the wall [48]) (Fig 10). This spectrum of pathologic features is found with similar frequency in primary pulmonary (more properly, "unexplained" [49]) hypertension and in cases of pulmonary hypertension with a known cause or association. Many attempts have been made to classify pulmonary hypertension in terms of functional consequences or clinical risk factors, the most comprehensive of these being one developed at a World Health Organization symposium on primary pulmonary hypertension (46).

View larger version (117K): [in this window] [in a new window] [Download PPT slide]   Figure 10a. Histopathologic features of pulmonary hypertension. (a) Photomicrograph shows muscular hypertrophy and subendothelial fibrosis in two small pulmonary arteries. (Original magnification, x400.) (b) Photomicrograph shows typical plexiform lesion, with several abnormal vascular channels (arrows) in the damaged wall of a small pulmonary artery. (Original magnification, x200.)

View larger version (139K): [in this window] [in a new window] [Download PPT slide]   Figure 10b. Histopathologic features of pulmonary hypertension. (a) Photomicrograph shows muscular hypertrophy and subendothelial fibrosis in two small pulmonary arteries. (Original magnification, x400.) (b) Photomicrograph shows typical plexiform lesion, with several abnormal vascular channels (arrows) in the damaged wall of a small pulmonary artery. (Original magnification, x200.)

View larger version (154K): [in this window] [in a new window] [Download PPT slide]   Figure 11. Transverse thin-section CT image (soft-tissue window settings) in a patient with primary pulmonary hypertension. In this patient with a mean pulmonary artery pressure of more than 35 mm Hg, the main pulmonary artery (pa) is dilated and there is fluid within the anterior (double-headed arrow) and posterior (arrowhead) superior pericardial recesses. A pericardial effusion was evident on more caudal sections (not shown).

Whether the distribution of the pathologic process in primary pulmonary hypertension (relatively uniform involvement of the small muscular pulmonary arteries, in comparison with patchy thrombotic occlusion of larger generations of pulmonary arteries in thromboembolic disease) is responsible for different manifestations—that is, loss of the normal gravity-dependent attenuation gradient in nonthromboembolic pulmonary hypertension (28) rather than a conspicuous mosaic attenuation pattern in thromboembolic disease (58)—has not yet been determined. The pathophysiology of chronic occlusive vascular disease may be complex. In some patients with advanced primary pulmonary hypertension, there is scintigraphic evidence of reversed mismatching (ie, pulmonary perfusion of areas of lung showing little or no ventilation); CT studies have shown that such areas show normal or engorged pulmonary vasculature, with areas of increased parenchymal attenuation that are shown to have ventilatory defects at scintigraphy (59).

There is the fascinating report (38) of small, poorly defined, low-attenuating centrilobular nodules in patients with pulmonary arterial hypertension of various causes. These nodules resemble those found in hypersensitivity pneumonitis, and at histologic examination are seen to consist mainly of cholesterol granulomas, possibly formed as a consequence of macrophage ingestion of red blood cells after repeated pulmonary hemorrhage (Fig 12). Two of the five patients included in that report (38) had primary pulmonary hypertension; the presence of a widespread nodular pattern on thin-section CT images clearly raises the possibility of a secondary (diffuse parenchymal) cause for pulmonary hypertension (eg, conditions characterized by a nodular pattern with a propensity to cause pulmonary hypertension, such as primary capillary hemangiomatosis [40] or Langerhans cell histiocytosis [10]). Because of the lack of specific features ascribable to most causes of pulmonary hypertension, these conditions (summarized in Table 2) will not be covered in any detail. However, two conditions that specifically affect the small vessels of the lungs—namely, pulmonary capillary hemangiomatosis and veno-occlusive disease—will be discussed.

View larger version (73K): [in this window] [in a new window] [Download PPT slide]   Figure 12a. Severe small-vessel vasculopathy thought to be a variant of veno-occlusive disease at histologic examination. (a) Transverse thin-section CT image through the lower lobes shows numerous poorly defined nodules (arrows) ranging from 1 to 4 mm in diameter, with a generalized increase in attenuation of lung parenchyma. (b) Low-power photomicrograph shows that nodules seen at CT correspond to small, scattered, focal areas of hemorrhage, most obvious in the bottom right-hand corner. (Original magnification, x20.)

View larger version (187K): [in this window] [in a new window] [Download PPT slide]   Figure 12b. Severe small-vessel vasculopathy thought to be a variant of veno-occlusive disease at histologic examination. (a) Transverse thin-section CT image through the lower lobes shows numerous poorly defined nodules (arrows) ranging from 1 to 4 mm in diameter, with a generalized increase in attenuation of lung parenchyma. (b) Low-power photomicrograph shows that nodules seen at CT correspond to small, scattered, focal areas of hemorrhage, most obvious in the bottom right-hand corner. (Original magnification, x20.)

View larger version (103K): [in this window] [in a new window] [Download PPT slide]   Figure 13a. Capillary hemangiomatosis. (a) Transverse thin-section CT image shows mosaic attenuation pattern in the lower lobes, with clear demarcation between areas of lung of differing attenuation. More cephalic sections (not shown) demonstrated marked dilatation of the proximal pulmonary arteries. (Image courtesy of Dr L. Mitchell, Freeman Hospital, Newcastle upon Tyne, England.) (b) Low-power photomicrograph of lung biopsy specimen shows clear demarcation between abnormal capillary proliferation causing thickening of interstitium (on the left), as compared with relatively normal lung (on the right). Small pulmonary arteries (arrowheads) at top of field show features of pulmonary hypertension; the patient was initially thought to have primary pulmonary hypertension. (Original magnification, x40.)

View larger version (154K): [in this window] [in a new window] [Download PPT slide]   Figure 13b. Capillary hemangiomatosis. (a) Transverse thin-section CT image shows mosaic attenuation pattern in the lower lobes, with clear demarcation between areas of lung of differing attenuation. More cephalic sections (not shown) demonstrated marked dilatation of the proximal pulmonary arteries. (Image courtesy of Dr L. Mitchell, Freeman Hospital, Newcastle upon Tyne, England.) (b) Low-power photomicrograph of lung biopsy specimen shows clear demarcation between abnormal capillary proliferation causing thickening of interstitium (on the left), as compared with relatively normal lung (on the right). Small pulmonary arteries (arrowheads) at top of field show features of pulmonary hypertension; the patient was initially thought to have primary pulmonary hypertension. (Original magnification, x40.)

View larger version (131K): [in this window] [in a new window] [Download PPT slide]   Figure 14. Transverse thin-section CT image through the lower lobes in a patient with veno-occlusive disease shows combination of thickening of interlobular septa (arrows), ground-glass opacity, and pleural effusions. Fluid is seen tracking into the right oblique fissure (arrowheads). (Image courtesy of Dr S. Swensen, Mayo Clinic, Rochester, Minn.)

View larger version (96K): [in this window] [in a new window] [Download PPT slide]   Figure 15a. (a) Transverse thin-section CT image through the upper lobes in a ventilated 27-year-old woman with acute sickle cell crisis shows mosaic attenuation pattern. Vessels within areas of reduced attenuation are of decreased caliber (arrowheads). Combined dependent atelectasis and pleural effusions can be seen. (b) Photomicrograph of open lung biopsy specimen shows engorgement of alveolar capillaries resulting from sludging and occlusion by sickle cells, most obvious on the left-hand side of the image. (Original magnification, x200.)

View larger version (152K): [in this window] [in a new window] [Download PPT slide]   Figure 15b. (a) Transverse thin-section CT image through the upper lobes in a ventilated 27-year-old woman with acute sickle cell crisis shows mosaic attenuation pattern. Vessels within areas of reduced attenuation are of decreased caliber (arrowheads). Combined dependent atelectasis and pleural effusions can be seen. (b) Photomicrograph of open lung biopsy specimen shows engorgement of alveolar capillaries resulting from sludging and occlusion by sickle cells, most obvious on the left-hand side of the image. (Original magnification, x200.)

View larger version (129K): [in this window] [in a new window] [Download PPT slide]   Figure 16a. Transverse thin-section CT images through the lower zones of two patients with chronic changes of sickle cell anemia. (a) Irregular linear subpleural opacities in the lower lobes (arrowheads), with associated distortion of the lung architecture, indicate interstitial fibrosis in a patient with repeated sickle cell crises. (b) The striking abnormality is diffuse ground-glass opacity: The pathologic correlate of this pattern in chronic sickle cell disease is uncertain. (Images courtesy of Dr S. Desai, King’s College Hospital, London, England.)

View larger version (107K): [in this window] [in a new window] [Download PPT slide]   Figure 16b. Transverse thin-section CT images through the lower zones of two patients with chronic changes of sickle cell anemia. (a) Irregular linear subpleural opacities in the lower lobes (arrowheads), with associated distortion of the lung architecture, indicate interstitial fibrosis in a patient with repeated sickle cell crises. (b) The striking abnormality is diffuse ground-glass opacity: The pathologic correlate of this pattern in chronic sickle cell disease is uncertain. (Images courtesy of Dr S. Desai, King’s College Hospital, London, England.)

Bronchopulmonary dysplasia.—There are two potential causes of extensive obliteration of the small pulmonary vessels in early life. The first is the exceedingly rare condition of congenital alveolar capillary dysplasia, in which there is a paucity of capillaries and abnormal pulmonary veins accompanying the pulmonary arteries within bronchovascular bundles (73). This dysplasia of the small pulmonary vessels causes pulmonary hypertension in the neonate.

An increasingly frequently encountered acquired cause of widespread obliteration of the small pulmonary vessels is found in individuals with bronchopulmonary dysplasia. Since the condition was first defined in 1967 (as oxygen dependency at 28 days of age with an accompanying abnormal chest radiograph) (74), there has been a dramatic increase in the number of premature neonates surviving into adulthood, with the consequences of early and prolonged ventilation (that contribute to bronchopulmonary dysplasia). From the relatively limited information available, it seems that all elements of the lungs—that is, the vasculature, airways, and lung parenchyma—are affected to a greater or lesser extent (75,76). The cardinal CT features of bronchopulmonary dysplasia in surviving adults are extensive areas of reduced lung attenuation, within which the size and number of vessels are reduced; widespread bronchial wall thickening; and a decreased bronchus-to–pulmonary artery diameter ratio (such that the airways may appear to be of strikingly reduced caliber). Some individuals show distortion of the lung parenchyma, with linear opacities and multiple bullae. Given that the histologic features of "healed" bronchopulmonary dysplasia include bronchial abnormalities, arrest of acinar development, and pulmonary arteriolar involvement (77), it is difficult in an individual case to confidently assign the areas of decreased attenuation on thin-section CT images to the consequences of parenchymal, bronchial, or vascular dysplasia. The morphologic sequelae of the similar situation in adults surviving acute respiratory distress syndrome are different: Thrombotic and fibroproliferative vascular occlusion occurs in the acute phase of disease (78,79); however, a mosaic attenuation pattern, indicating chronic occlusive vascular disease, is not a common feature in long-term survivors (80).

Miscellaneous causes.—As Table 2 shows, there are numerous potential causes of pulmonary hypertension, several of which can be regarded as having truly occlusive features. The thin-section CT findings for each cause will vary and be modulated by the exact nature of the underlying pathologic condition. For example, two recently reported causes of an occlusive vasculopathy include Langerhans cell histiocytosis (Fig 17) (10), with its characteristic cavitating nodular pattern, and microvascular emboli of precipitated crystals from parenteral nutrition (81), in which a granulomatous response to the intravascular particulate matter results in a micronodular appearance with a predominantly lower-zone distribution. There are other more or less exotic nonthrombotic embolic materials that may cause extensive occlusion of small pulmonary vessels, ranging from microscopic tumor emboli (82,83) to a variety of substances introduced intravenously by drug users (44).

View larger version (141K): [in this window] [in a new window] [Download PPT slide]   Figure 17a. Langerhans cell histiocytosis. (a) Transverse thin-section CT image shows fine reticulonodular pattern in the upper lobes, with relative sparing of the lower lobes. (b) Transverse contrast-enhanced CT image shows marked dilatation of the main pulmonary artery (arrowheads) relative to the ascending aorta (a), indicating severe pulmonary hypertension. (c) Photomicrograph of biopsy specimen in another patient shows Langerhans cell histiocytosis nodule involving and partly obliterating a pulmonary artery (arrowheads). (Original magnification, x20.) (Fig 17c courtesy of Dr F. Capron, Assistance Hôpitaux Publique de Paris, France.)

View larger version (92K): [in this window] [in a new window] [Download PPT slide]   Figure 17b. Langerhans cell histiocytosis. (a) Transverse thin-section CT image shows fine reticulonodular pattern in the upper lobes, with relative sparing of the lower lobes. (b) Transverse contrast-enhanced CT image shows marked dilatation of the main pulmonary artery (arrowheads) relative to the ascending aorta (a), indicating severe pulmonary hypertension. (c) Photomicrograph of biopsy specimen in another patient shows Langerhans cell histiocytosis nodule involving and partly obliterating a pulmonary artery (arrowheads). (Original magnification, x20.) (Fig 17c courtesy of Dr F. Capron, Assistance Hôpitaux Publique de Paris, France.)

View larger version (143K): [in this window] [in a new window] [Download PPT slide]   Figure 17c. Langerhans cell histiocytosis. (a) Transverse thin-section CT image shows fine reticulonodular pattern in the upper lobes, with relative sparing of the lower lobes. (b) Transverse contrast-enhanced CT image shows marked dilatation of the main pulmonary artery (arrowheads) relative to the ascending aorta (a), indicating severe pulmonary hypertension. (c) Photomicrograph of biopsy specimen in another patient shows Langerhans cell histiocytosis nodule involving and partly obliterating a pulmonary artery (arrowheads). (Original magnification, x20.) (Fig 17c courtesy of Dr F. Capron, Assistance Hôpitaux Publique de Paris, France.)

	INFLAMMATORY SMALL-VESSEL DISEASE

TOP ABSTRACT INTRODUCTION ANATOMIC AND HISTOLOGIC ASPECTS... CLASSIFICATION OF SMALL-VESSEL... IMAGING TECHNIQUES OCCLUSIVE SMALL-VESSEL DISEASES INFLAMMATORY SMALL-VESSEL... CONCLUSION REFERENCES

Selected Inflammatory Small-Vessel Diseases
Pulmonary capillaritis.—The pathologic feature of capillaritis is simply that of a neutrophilic infiltrate (Fig 18), with consequent necrosis, intraalveolar hemorrhage, and subsequent hemosiderin deposition (84). The situations in which this entity occurs and the associations with other clinically defined syndromes are not straightforward. In the past, cases of acute capillaritis (resulting in diffuse pulmonary hemorrhage with a clinical manifestation of hemoptysis, dyspnea, iron deficiency anemia, and widespread airspace shadowing on chest radiographs) were classified clinically. When there was no obvious cause, the label of idiopathic pulmonary hemorrhage (or hemosiderosis) was used. The conditions generally considered to be associated with neutrophilic capillaritis include various autoimmune diseases (including systemic lupus erythematosus [88] and Goodpasture syndrome), Henoch-Schönlein purpura (89) (a hypersensitivity vasculitis), cryoglobulinemia, acute pulmonary allograft rejection (90), and Wegener granulomatosis (only rarely is capillaritis the sole manifestation of Wegener granulomatosis). Of these, Goodpasture syndrome (antiglomerular basement membrane antibody disease) is probably the commonest cause of diffuse pulmonary hemorrhage (29,91). In addition, there is an increasing appreciation that there are many variations of immune-mediated capillaritis (86). So-called isolated pauciimmune pulmonary capillaritis is a recently described entity in which there is no obviously associated systemic disease, but, confusingly, patients may be positive for perinuclear ANCA (92,93).

View larger version (186K): [in this window] [in a new window] [Download PPT slide]   Figure 18. Pulmonary capillaritis. Photomicrograph shows intense neutrophilic infiltration within the wall (arrowheads) of a small pulmonary artery (neutrophilic vasculitis), with some extravasation of red blood cells into surrounding airspaces. (Original magnification, x400.)

View larger version (105K): [in this window] [in a new window] [Download PPT slide]   Figure 19. Transverse thin-section CT image through the lower lobes in a 31-year-old patient with Goodpasture syndrome shows combination of widespread areas of ground-glass opacity, with poorly defined nodular elements and more intense opacification within the right middle lobe (arrowheads), reflecting extravasation of blood into the airspaces.

Wegener granulomatosis.—Wegener granulomatosis is a necrotizing granulomatous vasculitis that affects the upper respiratory tract, lungs, and kidneys. At least 90% of patients have pulmonary involvement, and the typical radiographic findings are of bilateral multiple opacities, some of which show cavitation, ranging from less than 1 cm to 10 cm in diameter. Other frequent findings include larger masslike lesions and wedge-shaped areas of consolidation abutting the pleura (33,87,101,102). The histologic diagnosis requires positive identification of necrotizing vasculitis, and the predominant vessels affected are the medium-sized muscular arteries, although veins are also involved (84). It is probably the necrosis and obliteration of these larger vessels that account for the radiographic appearances of pulmonary infarcts. Nevertheless, a small-vessel vasculitis sited mainly in alveolar septal capillaries and small arterioles and venules is also encountered in Wegener granulomatosis (86).

At a histologic level, capillary involvement is usually found at the edges of more typical granulomatous vasculitis, but occasionally it will be the sole pulmonary manifestation of Wegener granulomatosis (103,104). Nevertheless, diffuse pulmonary hemorrhage as a manifestation of "Wegener’s capillaritis," without the more typical histologic and radiographic abnormalities remains rare, with only approximately 40 cases reported in the literature (86). In these unusual cases of pure small-vessel involvement in Wegener granulomatosis, the resulting diffuse pulmonary hemorrhage produces the nonspecific thin-section CT appearances described above in the paragraph on idiopathic pulmonary hemorrhage (Fig 20). In cases in which there is an accompanying focal segmental necrotizing glomerular nephritis and the serum cytoplasmic-pattern–ANCA is positive, the diagnosis of Wegener granulomatosis is secure. However, ANCA type and positivity are variable, often making the diagnosis uncertain, and this highlights the overlap with other inflammatory small-vessel diseases such as microscopic polyangiitis (86).

View larger version (117K): [in this window] [in a new window] [Download PPT slide]   Figure 20. Transverse thin-section CT image through the upper lobes in a 45-year-old man with Wegener granulomatosis. This is an unusual manifestation of Wegener granulomatosis, with widespread areas of ground-glass opacity and intense opacification (there were no nodules or cavitating masses elsewhere). The pathologic correlate of this CT pattern is diffuse pulmonary hemorrhage as consequence of a pulmonary capillaritis.

A fascinating consequence of repeated episodes of pulmonary hemorrhage caused by microscopic polyangiitis or capillaritis has been reported by Schwarz et al (27): In two patients with biopsy-proved pulmonary capillaritis and systemic vasculitis, severe airflow limitation developed 10 years after the onset of disease. The exact nature of the airflow limitation was not established, and the authors speculate that in one of the two patients the development of emphysema (shown on thin-section CT images) may have been accelerated by the release of oxygen radicals and proteolytic enzymes as a consequence of recurrent hemorrhage. This intriguing sequel to repeated pulmonary hemorrhage has been reported in another case of microscopic polyangiitis (109).

Churg-Strauss syndrome (allergic angiitis and granulomatosis).—Although included in any consideration of the inflammatory vasculitides, Churg-Strauss syndrome is the least common and least well characterized in terms of pathologic descriptions (84,85) and imaging findings (32,87,110). The disease is characterized by hypereosinophilia, asthma, and multisystem vasculitis. The histologic findings are of necrotizing vasculitis and coexisting eosinophilic pneumonia; while the vasculitis affects both arteries and veins, a predominant or exclusive small-vessel involvement is rarely (if ever) encountered, and it is therefore not surprising that diffuse pulmonary hemorrhage is an uncommon manifestation of Churg-Strauss syndrome (86). The thin-section CT appearances in Churg-Strauss syndrome largely reflect the eosinophilic infiltrate and are largely nonspecific (32,110). Furthermore, a substantial proportion (up to 25%) of patients with Churg-Strauss syndrome have few or no imaging abnormalities (32,85), and imaging can be regarded as of little help in making this elusive diagnosis (111). Although the authors of a single report (112) have suggested that stellate enlargement of the pulmonary arteries lying perpendicular to the plain of a thin-section CT image might be characteristic (112), this has not been confirmed.

	CONCLUSION

TOP ABSTRACT INTRODUCTION ANATOMIC AND HISTOLOGIC ASPECTS... CLASSIFICATION OF SMALL-VESSEL... IMAGING TECHNIQUES OCCLUSIVE SMALL-VESSEL DISEASES INFLAMMATORY SMALL-VESSEL... CONCLUSION REFERENCES

 
In this review, emphasis has been placed on the basic distinction between occlusive and inflammatory diseases of the small vessels of the lungs. An advantage of this simple categorization is the corresponding distinct differences in the CT manifestations of occlusive versus inflammatory small-vessel diseases. The CT features of the inflammatory vasculitides are usually florid and nonspecific. However, appreciation of the CT abnormalities that characterize occlusive small-vessel diseases aids understanding of their sometimes complex pathophysiology and may be helpful in suggesting the presence of these elusive disorders.

	FOOTNOTES

 
Abbreviation: ANCA = antineutrophil cytoplasmic antibody

	REFERENCES

TOP ABSTRACT INTRODUCTION ANATOMIC AND HISTOLOGIC ASPECTS... CLASSIFICATION OF SMALL-VESSEL... IMAGING TECHNIQUES OCCLUSIVE SMALL-VESSEL DISEASES INFLAMMATORY SMALL-VESSEL... CONCLUSION REFERENCES

 

1. Harris P, Heath D. The human pulmonary circulation 3rd ed. Edinburgh, Scotland: Churchill Livingstone, 1986.
2. Reid LM. Structure and function in pulmonary hypertension: new perceptions. Chest 1986; 89:279-286.[Free Full Text]
3. Murata K, Itoh H, Todo G, et al. Centrilobular lesions of the lung: demonstration by high-resolution CT and pathologic correlation. Radiology 1986; 161:641-645.[Abstract/Free Full Text]
4. Austin JHM, Müller NL, Friedman PJ, et al. Glossary of terms for CT of the lungs: recommendations of the nomenclature committee of the Fleischner Society. Radiology 1996; 200:327-331.[Free Full Text]
5. Hislop AA, Reid LM. Pulmonary arterial development during childhood: branching pattern and structure. Thorax 1973; 28:129-135.[Abstract/Free Full Text]
6. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: proposal on an international consensus conference. Arth Rheum 1993; 37:187-192.
7. Anderson G. Pulmonary vasculitis. In: Peacock AJ, eds. Pulmonary circulation. London, England: Chapman & Hall, 1996; 377-390.
8. Yamasaki S, Eguchi K, Kawabe Y, Tsukada T, Nagataki S. Wegener’s granulomatosis overlapped with Takayasu arteritis. Clin Rheumatol 1996; 15:303-306.[CrossRef][Medline]
9. Dufour B, Maitre S, Humbert M, Capron F, Simonneau G, Musset D. High-resolution CT of the chest in four patients with pulmonary capillary hemangiomatosis or pulmonary veno-occlusive disease. AJR Am J Roentgenol 1998; 171:1321-1324.[Abstract/Free Full Text]
10. Fartoukh M, Humbert M, Capron F, et al. Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 2000; 161:216-223.[Abstract/Free Full Text]
11. Webb WR, Gamsu G, Wall SD, Cann CE, Proctor E. CT of a bronchial phantom: factors affecting appearance and size measurements. Invest Radiol 1984; 19:394-398.[Medline]
12. Maguire WM, Herman PG, Khan A, et al. Comparison of fixed and adjustable window width and level settings in the CT evaluation of diffuse lung disease. J Comput Assist Tomogr 1993; 17:847-852.[Medline]
13. Sherrick AD, Swensen SJ, Hartman TE. Mosaic pattern of lung attenuation on CT scans: frequency among patients with pulmonary artery hypertension of different causes. AJR Am J Roentgenol 1997; 169:79-82.[Abstract/Free Full Text]
14. Primack SL, Müller NL, Mayo JR, Remy-Jardin M, Remy J. Pulmonary parenchymal abnormalities of vascular origin: high-resolution CT findings. RadioGraphics 1994; 14:739-746.[Abstract]
15. Martin KW, Sagel SS, Siegel BA. Mosaic oligemia simulating pulmonary infiltrates on CT. AJR Am J Roentgenol 1986; 147:670-673.[Free Full Text]
16. Stern EJ, Swensen SJ, Hartman TE, Frank MS. CT mosaic pattern of lung attenuation: distinguishing different causes. AJR Am J Roentgenol 1995; 165:813-816.[Abstract/Free Full Text]
17. Worthy SA, Müller NL, Hartman TE, Swensen SJ, Padley SP, Hansell DM. Mosaic attenuation pattern on thin-section CT scans of the lung: differentiation among infiltrative lung, airway, and vascular diseases as a cause. Radiology 1997; 205:465-470.[Abstract/Free Full Text]
18. Arakawa H, Webb WR, McCowin M, et al. Inhomogeneous lung attenuation at thin-section CT: diagnostic value of expiratory scans. Radiology 1998; 206:89-94.[Abstract/Free Full Text]
19. Arakawa H, Webb WR. Air trapping on expiratory high-resolution CT scans in the absence of inspiratory scan abnormalities: correlation with pulmonary function tests and differential diagnosis. AJR Am J Roentgenol 1998; 170:1349-1353.[Abstract/Free Full Text]
20. Stern EJ, Frank MS. Small-airways disease of the lungs: findings at expiratory CT. AJR Am J Roentgenol 1994; 163:37-41.[Abstract/Free Full Text]
21. Remy-Jardin M, Remy J, Louvegny S, Artaud D, Deschildre F, Duhamel A. Airway changes in chronic pulmonary embolism: CT findings in 33 patients. Radiology 1997; 203:355-360.[Abstract/Free Full Text]
22. Remy-Jardin M, Remy J, Gosselin B, Copin MC, Wurtz A, Duhamel A. Sliding thin slab, minimum intensity projection technique in the diagnosis of emphysema: histopathologic-CT correlation. Radiology 1996; 200:665-671.[Abstract/Free Full Text]
23. Fotheringham T, Chabat F, Hansell DM, et al. A comparison of methods for enhancing the detection of areas of decreased attenuation on CT caused by airways disease. J Comput Assist Tomogr 1999; 23:385-389.[CrossRef][Medline]
24. Remy J, Remy-Jardin M, Artaud D, Fribourg M. Multiplanar and three-dimensional reconstruction techniques in CT: impact on chest diseases. Eur Radiol 1998; 8:335-351.[CrossRef][Medline]
25. Remy-Jardin M, Remy J, Giraud F, Wattinne L, Gosselin B. Computed tomography (CT) assessment of ground-glass opacity: semiology and significance. J Thorac Imaging 1993; 8:249-264.[Medline]
26. Stern EJ, Müller NL, Swensen SJ, Hartman TE. CT mosaic pattern of lung attenuation: etiologies and terminology. J Thorac Imaging 1995; 10:294-297.[Medline]
27. Schwarz MI, Mortenson RL, Colby TV, et al. Pulmonary capillaritis: the association with progressive irreversible airflow limitation and hyperinflation. Am Rev Respir Dis 1993; 148:507-511.[Medline]
28. Cailes JB, Du Bois RM, Hansell DM. Density gradient of the lung parenchyma on CT in patients with lone pulmonary hypertension and systemic sclerosis. Acad Radiol 1996; 3:724-730.[CrossRef][Medline]
29. Primack SL, Miller RR, Müller NL. Diffuse pulmonary hemorrhage: clinical, pathologic, and imaging features. AJR Am J Roentgenol 1995; 2:295-300.
30. Swensen SJ, Tashjian JH, Myers JL, et al. Pulmonary veno-occlusive disease: CT findings in eight patients. AJR Am J Roentgenol 1996; 167:937-940.[Abstract/Free Full Text]
31. Bhalla M, Abboud MR, McLoud TC, et al. Acute chest syndrome in sickle cell disease: CT evidence of microvascular occlusion. Radiology 1993; 187:45-49.[Abstract/Free Full Text]
32. Worthy SA, Müller NL, Hansell DM, Flower CD. Churg-Strauss syndrome: the spectrum of pulmonary CT findings in 17 patients. AJR Am J Roentgenol 1998; 170:297-300.[Abstract/Free Full Text]
33. Aberle DR, Gamsu G, Lynch D. Thoracic manifestations of Wegener granulomatosis: diagnosis and course. Radiology 1990; 174:703-709.[Abstract/Free Full Text]
34. Attali P, Begum R, Ban RH, Valeyre D, Guillevin L, Brauner MW. Pulmonary Wegener’s granulomatosis: changes at follow-up CT. Eur Radiol 1998; 8:1009-1113.[CrossRef][Medline]
35. Lee KS, Kim TS, Han J, et al. Diffuse micronodular lung disease: HRCT and pathologic findings. J Comput Assist Tomogr 1999; 23:99-106.[CrossRef][Medline]
36. Buckley JA, Scott WWJ, Siegelman SS, et al. Pulmonary nodules: effect of increased data sampling on detection with spiral CT and confidence in diagnosis. Radiology 1995; 196:395-400.[Abstract/Free Full Text]
37. Lee KN, Lee HJ, Shin WW, Webb WR. Hypoxemia and liver cirrhosis (hepatopulmonary syndrome) in eight patients: comparison of the central and peripheral pulmonary vasculature. Radiology 1999; 211:549-553.[Abstract/Free Full Text]
38. Nolan RL, McAdams HP, Sporn TA, Roggli VL, Tapson VF, Goodman PC. Pulmonary cholesterol granulomas in patients with pulmonary artery hypertension: chest radiographic and CT findings. AJR Am J Roentgenol 1999; 172:1317-1319.[Abstract/Free Full Text]
39. Cheah FK, Sheppard MN, Hansell DM. Computed tomography of diffuse pulmonary haemorrhage with pathological correlation. Clin Radiol 1993; 48:89-93.[CrossRef][Medline]
40. Lippert JL, White CS, Cameron EW, Sun CC, Liang X, Rubin LJ. Pulmonary capillary hemangiomatosis: radiographic appearance. J Thorac Imaging 1998; 13:49-51.[Medline]
41. Shepard JA, Moore EH, Templeton PA, McLoud TC. Pulmonary intravascular tumor emboli: dilated and beaded peripheral pulmonary arteries at CT. Radiology 1993; 187:797-801.[Abstract/Free Full Text]
42. Yao DX, Flieder DB, Hoda SA. Pulmonary tumor thrombotic microangiopathy: an often missed antemortem diagnosis. Arch Pathol Lab Med 2001; 125:304-305.[Medline]
43. Bendeck SE, Leung AN, Berry GJ, Daniel D, Ruoss SJ. Cellulose granulomatosis presenting as centrilobular nodules: CT and histologic findings. AJR Am J Roentgenol 2001; 177:1151-1153.[Free Full Text]
44. Rossi SE, Goodman PC, Franquet T. Nonthrombotic pulmonary emboli. AJR Am J Roentgenol 2000; 174:1499-1508.[Free Full Text]
45. Katzenstein AL, Askin FB. Pulmonary hypertension and other vascular disorders. In: Bennington JL, eds. Surgical pathology of non-neoplastic lung disease. 2nd ed. Philadelphia, Pa: Saunders, 1990; 432-467.
46. Peacock AJ. Primary pulmonary hypertension. Thorax 1999; 54:1107-1118.[Free Full Text]
47. Peacock AJ. Commentary: unusual causes of pulmonary hypertension. Thorax 1997; 52:1013.[Medline]
48. Wagenvoort CA. Primary pulmonary hypertension: pathology. In: Peacock AJ, eds. Pulmonary circulation. London, England: Chapman & Hall, 1996; 325-328.
49. Fishman AP. Unexplained pulmonary hypertension. Circulation 1982; 65:651-652.[Free Full Text]
50. Ravin CE. Pulmonary vascularity: radiographic considerations. J Thorac Imaging 1988; 3:1-13.[Medline]
51. Kuriyama K, Gamsu G, Stern RG, Cann CE, Herfkens RJ, Brundage BH. CT determined pulmonary artery diameters in predicting pulmonary hypertension. Invest Radiol 1984; 19:16-22.[Medline]
52. Haimovici JB, Trotman-Dickenson B, Halpern EF, et al. Relationship between pulmonary artery diameter at computed tomography and pulmonary artery pressures at right-sided heart catheterization: Massachusetts General Hospital Lung Transplantation Program. Acad Radiol 1997; 4:327-334.[CrossRef][Medline]
53. Tan RT, Kuzo R, Goodman LR, Siegel R, Haasler GB, Presberg KW. Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease: Medical College of Wisconsin Lung Transplant Group. Chest 1998; 113:1250-1256.[Abstract/Free Full Text]
54. Ng CS, Wells AU, Padley SP. A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter. J Thorac Imaging 1999; 14:270-278.[Medline]
55. Baque-Juston MC, Wells AU, Hansell DM. Pericardial thickening or effusion in patients with pulmonary artery hypertension: a CT study. AJR Am J Roentgenol 1999; 172:361-364.[Abstract/Free Full Text]
56. King MA, Ysrael M, Bergin CJ. Chronic thromboembolic pulmonary hypertension: CT findings. AJR Am J Roentgenol 1998; 170:955-960.[Free Full Text]
57. King MA, Bergin CJ, Yeung DW, et al. Chronic pulmonary thromboembolism: detection of regional hypoperfusion with CT. Radiology 1994; 191:359-363.[Abstract/Free Full Text]
58. Bergin CJ, Rios G, King MA, Belezzuoli E, Luna J, Auger WR. Accuracy of high-resolution CT in identifying chronic pulmonary thromboembolic disease. AJR Am J Roentgenol 1996; 166:1371-1377.[Abstract/Free Full Text]
59. Engeler CE, Kuni CC, Tashjian JH, Engeler CM, du Cret RP. Regional alterations in lung ventilation in end-stage primary pulmonary hypertension: correlation between CT and scintigraphy. AJR Am J Roentgenol 1995; 164:831-835.[Abstract/Free Full Text]
60. Eltorky MA, Headley AS, Winer-Muram H, Garrett HE, Griffin JP. Pulmonary capillary hemangiomatosis: a clinicopathologic review. Ann Thorac Surg 1994; 57:772-776.[Abstract]
61. Pycock CJ, Thomas AJ, Marshall AJ, Scarratt W. Capillary haemangiomatosis: a rare cause of pulmonary hypertension. Respir Med 1994; 88:153-155.[CrossRef][Medline]
62. Stuart MJ, Setty BN. Sickle cell acute chest syndrome: pathogenesis and rationale for treatment. Blood 1999; 94:1555-1560.[Abstract/Free Full Text]
63. Leong CS, Stark P. Thoracic manifestations of sickle cell disease. J Thorac Imaging 1998; 13:128-134.[Medline]
64. Aquino SL, Gamsu G, Fahy JV, et al. Chronic pulmonary disorders in sickle cell disease: findings at thin-section CT. Radiology 1994; 193:807-811.[Abstract/Free Full Text]
65. White DC. The histopathologic basis for functional decrements in late radiation injury in diverse organs. Cancer 1976; 37:1126-1143.[CrossRef][Medline]
66. Wilkinson MJ, Maclennan KA. Vascular changes in irradiated lungs: a morphometric study. J Pathol 1989; 158:229-232.[CrossRef][Medline]
67. Pagani JJ, Libshitz HI. CT manifestations of radiation-induced change in chest tissue. J Comput Assist Tomogr 1982; 6:243-248.[Medline]
68. Ikezoe J, Takashima S, Morimoto S, et al. CT appearance of acute radiation-induced injury in the lung. AJR Am J Roentgenol 1988; 150:765-770.[Abstract/Free Full Text]
69. Schratter-Sehn AU, Schurawitzki H, Zach M, Schratter M. High-resolution computed tomography of the lungs in irradiated breast cancer patients. Radiother Oncol 1993; 27:198-202.[CrossRef][Medline]
70. Rotstein S, Lax I, Svane G. Influence of radiation therapy on the lung-tissue in breast cancer patients: CT-assessed density changes and associated symptoms. Int J Radiat Oncol Biol Phys 1990; 18:173-180.[Medline]
71. Svane G, Rotstein S, Lax I. Influence of radiation therapy on lung tissue in breast cancer patients: CT-assessed density changes 4 years after completion of radiotherapy. Acta Oncol 1995; 34:845-849.[Medline]
72. Lind PA, Svane G, Gagliardi G, Svensson C. Abnormalities by pulmonary regions studied with computer tomography following local or local-regional radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys 1999; 43:489-496.[CrossRef][Medline]
73. Janney CG, Askin FB, Kuhn CK. Congenital alveolar capillary dysplasia: an unusual cause of respiratory distress in the newborn. Am J Clin Pathol 1981; 76:722-724.[Medline]
74. Northway WH, Rosan RC, Porter DY. Pulmonary disease following respiratory therapy of hyaline membrane disease. N Engl J Med 1967; 276:357-368.
75. Howling SJ, Northway WH, Hansell DM, Moss RB, Ward S, Müller NL. Pulmonary sequelae of bronchopulmonary dysplasia survivors: high-resolution CT findings. AJR Am J Roentgenol 2000; 174:1323-1326.[Abstract/Free Full Text]
76. Aquino SL, Schechter MS, Chiles C, et al. High-resolution inspiratory and expiratory CT in older children and adults with bronchopulmonary dysplasia. AJR Am J Roentgenol 1999; 173:963-967.[Abstract/Free Full Text]
77. Stocker JT. Pathologic features of longstanding "healed" bronchopulmonary dysplasia. Hum Pathol 1986; 17:943-961.[Medline]
78. Tomashefski JF, Jr. Pulmonary pathology of the adult respiratory distress syndrome. Clin Chest Med 1990; 11:593-619.[Medline]
79. Greene R, Zapol WM, Snider MT, et al. Early bedside detection of pulmonary vascular occlusion during acute respiratory failure. Am Rev Respir Dis 1981; 124:593-601.[Medline]
80. Desai SR, Wells AU, Rubens MB, Evans TW, Hansell DM. Acute respiratory distress syndrome: CT abnormalities at long-term follow-up. Radiology 1999; 210:29-35.[Abstract/Free Full Text]
81. Reedy JS, Kuhlman JE, Voytovich M. Microvascular pulmonary emboli secondary to precipitated crystals in a patient receiving total parenteral nutrition: a case report and description of the high-resolution CT findings. Chest 1999; 115:892-895.[Abstract/Free Full Text]
82. Singh SP, Nath H, Pinkard NB, Alexander CB. Bronchioloalveolar carcinoma causing pulmonary hypertension: a unique manifestation. AJR Am J Roentgenol 1994; 162:30-32.[Free Full Text]
83. Hibbert M, Braude S. Tumour microembolism presenting as "primary pulmonary hypertension.". Thorax 1997; 552:1016-1017.
84. Katzenstein AL, Askin FB. Angiitis and granulomatosis. In: Bennington JL, eds. Surgical pathology of non-neoplastic lung disease. Philadelphia, Pa: Saunders, 1990; 252-289.
85. Frazier AA, Rosado-de-Christenson ML, Galvin JR, Fleming MV. Pulmonary angiitis and granulomatosis: radiologic-pathologic correlation. RadioGraphics 1998; 18:687-710.[Abstract]
86. Schwarz MI, Brown KK. Small vessel vasculitis of the lung. Thorax 2000; 55:502-510.[Free Full Text]
87. Seo JB, Im JG, Chung JW, et al. Pulmonary vasculitis: the spectrum of radiological findings. Br J Radiol 2000; 73:1224-1231.[Abstract]
88. Zamora MR, Warner ML, Tuder R, et al. Diffuse alveolar hemorrhage and systemic lupus erythematosus (SLE): clinical presentation, histology, survival and outcome. Medicine 1997; 76:192-202.[CrossRef][Medline]
89. Markus HS, Clark JV. Pulmonary haemorrhage in Henoch-Schonlein purpura. Thorax 1989; 44:525-526.[Abstract/Free Full Text]
90. Badesch DB, Zamora M, Fullerton D, et al. Pulmonary capillaritis: a possible histologic form of acute pulmonary allograft rejection. J Heart Lung Transplant 1998; 17:415-422.[Medline]
91. Ball JA, Young KR. Pulmonary manifestations of Goodpasture’s syndrome: antiglomerular basement membrane disease and related disorders. Clin Chest Med 1998; 19:777-791.[CrossRef][Medline]
92. Jennings CA, King TE, Tuder R, et al. Diffuse alveolar hemorrhage with underlying isolated pauciimmune pulmonary capillaritis. Am J Respir Crit Care Med 1997; 155:1101-1109.[Abstract]
93. Bosch X, Lopez-Soto A, Mirapeix E, et al. Antineutrophil cytoplasmic antibody-associated alveolar capillaritis in patients presenting with pulmonary hemorrhage. Pathol Lab Med 1994; 118:517-522.
94. Copley SJ, Coren M, Nicholson AG, Rubens MB, Bush A, Hansell DM. Diagnostic accuracy of thin-section CT and chest radiography of pediatric interstitial lung disease. AJR Am J Roentgenol 2000; 174:549-554.[Abstract/Free Full Text]
95. Marasco WJ, Fishman EK, Kuhlman JE, Hruban RH. Acute pulmonary hemorrhage: CT evaluation. Clin Imaging 1993; 17:77-80.[CrossRef][Medline]
96. Marshall TJ, Flower CD, Jackson JE. The role of radiology in the investigation and management of patients with haemoptysis. Clin Radiol 1996; 51:391-400.[CrossRef][Medline]
97. McGuinness G, Beacher JR, Harkin TJ, Garay SM, Rom WN, Naidich DP. Hemoptysis: prospective high-resolution CT/bronchoscopic correlation. Chest 1994; 105:1155-1162.[Abstract/Free Full Text]
98. Millar AB, Boothroyd AE, Edwards D, Hetzel MR. The role of computed tomography (CT) in the investigation of unexplained haemoptysis. Respir Med 1992; 86:39-44.[Medline]
99. Schwarz MI. Pulmonary capillaritis. Pulm Perspect 1994; 11:4-6.
100. Schnabel A, Reuter M, Csernok E, Richter C, Gross WL. Subclinical alveolar bleeding in pulmonary vasculitides: correlation with indices of disease activity. Eur Respir J 1999; 14:118-124.[Abstract]
101. Kuhlman JE, Hruban RH, Fishman EK. Wegener granulomatosis: CT features of parenchymal lung disease. J Comput Assist Tomogr 1991; 15:948-952.[Medline]
102. Maskell GF, Lockwood CM, Flower CD. Computed tomography of the lung in Wegener’s granulomatosis. Clin Radiol 1993; 48:377-380.[CrossRef][Medline]
103. Myers JL, Katzenstein AL. Wegener’s granulomatosis presenting with massive pulmonary hemorrhage and capillaritis. Am J Surg Pathol 1987; 11:895-897.[CrossRef][Medline]
104. Travis WD, Carpenter HA, Lie JT. Diffuse pulmonary hemorrhage: an uncommon manifestation of Wegener’s granulomatosis. Am J Surg Pathol 1987; 11:702-704.[CrossRef][Medline]
105. Doebbeling BN, Bonsib SM, Walker WP. Pulmonary-renal syndrome with "triad" involvement due to small vessel vasculitis. J Rheumatol 1990; 17:1087-1090.[Medline]
106. Imoto EM, Lombard CM, Sachs DP. Pulmonary capillaritis and hemorrhage: a clue to the diagnosis of systemic necrotizing vasculitis. Chest 1989; 96:927-928.[Abstract/Free Full Text]
107. Savage CO, Winearls CG, Evans DJ, Rees AJ, Lockwood CM. Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 1985; 56:467-483.
108. Zashin S, Fattor R, Fortin D. Microscopic polyarteritis: a forgotten aetiology of haemoptysis and rapidly progressive glomerulonephritis. Ann Rheum Dis 1990; 49:53-56.[Abstract/Free Full Text]
109. Brugiere O, Raffy O, Sleiman C, et al. Progressive obstructive lung disease associated with microscopic polyangiitis. Am J Respir Crit Care Med 1997; 155:739-742.[Abstract]
110. Choi YH, Im JG, Han BK, Kim JH, Lee KY, Myoung NH. Thoracic manifestation of Churg-Strauss syndrome: radiologic and clinical findings. Chest 2000; 117:117-124.[Abstract/Free Full Text]
111. Conron M, Benyon HLC. Churg-Strauss syndrome. Thorax 2000; 55:870-877.[Free Full Text]
112. Buschman DL, Waldron JA, King TE. Churg-Strauss pulmonary vasculitis. Am Rev Respir Dis 1990; 142:458-461.[Medline]

This article has been cited by other articles:

				L. Ananthakrishnan, N. Sharma, and J. P. Kanne Wegener's Granulomatosis in the Chest: High-Resolution CT Findings Am. J. Roentgenol., March 1, 2009; 192(3): 676 - 682. [Abstract] [Full Text] [PDF]

				R. Sheehan, J. K. Perloff, M. C. Fishbein, D. Gjertson, and D. R. Aberle Pulmonary Neovascularity: A Distinctive Radiographic Finding in Eisenmenger Syndrome Circulation, November 1, 2005; 112(18): 2778 - 2785. [Abstract] [Full Text] [PDF]

				M. Heinrich, M. Uder, D. Tscholl, A. Grgic, B. Kramann, and H.-J. Schafers CT Scan Findings in Chronic Thromboembolic Pulmonary Hypertension: Predictors of Hemodynamic Improvement After Pulmonary Thromboendarterectomy Chest, May 1, 2005; 127(5): 1606 - 1613. [Abstract] [Full Text] [PDF]

				K. Marten, P. Schnyder, E. Schirg, M. Prokop, E. J. Rummeny, and C. Engelke Pattern-Based Differential Diagnosis in Pulmonary Vasculitis Using Volumetric CT Am. J. Roentgenol., March 1, 2005; 184(3): 720 - 733. [Full Text] [PDF]

				F. D. Knollmann, S. Kapell, H. Lehmkuhl, B. Schulz, H. Bottcher, R. Hetzer, and R. Felix Dynamic High-Resolution Electron-Beam CT Scanning for the Diagnosis of Bronchiolitis Obliterans Syndrome After Lung Transplantation Chest, August 1, 2004; 126(2): 447 - 456. [Abstract] [Full Text] [PDF]

				S. S. Raman, D. Aziz, X. Chang, M. Ye, J. Sayre, C. Lassman, and D. S. K. Lu Minimizing Central Bile Duct Injury during Radiofrequency Ablation: Use of Intraductal Chilled Saline Perfusion--Initial Observations from a Study in Pigs Radiology, July 1, 2004; 232(1): 154 - 159. [Abstract] [Full Text] [PDF]

This Article Abstract Figures Only Full Text (PDF) All Versions of this Article: 2253011490v1 225/3/639    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hansell, D. M. Search for Related Content PubMed PubMed Citation Articles by Hansell, D. M.